TJX Cos Inc/The/ US8725401090 /
12.01.2024 15:12:37 | Diff. - | Volumen | Geld17:28:33 | Brief17:28:33 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
86,86EUR | - | 15 Umsatz: 1.302,90 |
-Geld Vol: - | -Brief Vol: - | 117,31 Mrd.EUR | - | - |
GlobeNewswire
08:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
07:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
07:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
07:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
06:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
03:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
03:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite